Modifying the osteoblastic niche with zoledronic acid in vivo—Potential implications for breast cancer bone metastasis

INTRODUCTION: Bone metastasis is the most common complication of advanced breast cancer. The associated cancer-induced bone disease is treated with bone-sparing agents like zoledronic acid. Clinical trials have shown that zoledronic acid also reduces breast cancer recurrence in bone; potentially by...

Descripción completa

Detalles Bibliográficos
Autores principales: Haider, Marie-Therese, Holen, Ingunn, Dear, T. Neil, Hunter, Keith, Brown, Hannah K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2014
Materias:
Original Full Length Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4127787/
https://www.ncbi.nlm.nih.gov/pubmed/24971713
http://dx.doi.org/10.1016/j.bone.2014.06.023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4127787/
https://www.ncbi.nlm.nih.gov/pubmed/24971713
http://dx.doi.org/10.1016/j.bone.2014.06.023

Ejemplares similares